Sagimet Biosciences Inc Series A (SGMT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Sales | 0 | 0 | 0 | 0 | 2,000 |
| Gross Profit | N/A | N/A | N/A | N/A | 2,000 |
| Operating Expenses | 16,902 | 10,589 | 8,768 | 9,466 | 9,452 |
| Operating Income | -16,902 | -10,589 | -8,768 | -9,466 | -7,452 |
| Other Income | 2,283 | 2,471 | 2,139 | 1,313 | 1,099 |
| Pre-tax Income | -14,619 | -8,118 | -6,629 | -8,153 | -6,353 |
| Net Income Continuous | -14,619 | -8,118 | -6,629 | -8,153 | -6,353 |
| Net Income | $-14,619 | $-8,118 | $-6,629 | $-8,153 | $-6,353 |
| EPS Basic Total Ops | -0.45 | -0.25 | -0.23 | 69.07 | -0.35 |
| EPS Basic Continuous Ops | -0.45 | -0.25 | -0.23 | 69.05 | -0.35 |
| EPS Diluted Total Ops | -0.45 | -0.25 | -0.23 | 69.07 | -0.35 |
| EPS Diluted Continuous Ops | -0.45 | -0.25 | -0.23 | 69.05 | -0.35 |
| EPS Diluted Before Non-Recurring Items | -0.45 | -0.25 | -0.23 | N/A | N/A |
| EBITDA(a) | $-17,429 | $-11,066 | $-8,961 | $-9,464 | $-7,452 |